TY - GEN
T1 - Uncertainty in clinical data and stochastic model for in-vitro fertilization
AU - Yenkie, Kirti M.
AU - Diwekar, Urmila
N1 - Publisher Copyright:
© Copyright American Institute of Chemical Engineers. All rights reserved.
PY - 2014
Y1 - 2014
N2 - In-vitro Fertilization (IVF) is the most common technique in Assisted Reproductive Technology (ART). It has been divided into four stages; (i) superovulation, (ii) egg retrieval, (iii) insemination/fertilization and (iv) embryo transfer. The first stage of superovulation is a drug induced method to enable multiple ovulation, i.e., multiple follicle growth to oocytes or matured follicles in a single menstrual cycle. IVF being a medical procedure that aims at manipulating the biological functions in the human body is subjected to inherent sources of uncertainty and variability. Also, the interplay of the hormones with the natural functioning of the ovaries to stimulate multiple ovulation as against a single ovulation in a normal menstrual cycle makes the procedure dependent on several factors like the patient's condition in terms of cause of infertility, actual ovarian function, responsiveness to the medication. The treatment requires continuous monitoring and testing and this can give rise to errors in observations and reports. These uncertainties can be observed in the form of measurement noise in the available data. Thus, it becomes essential to look at the process noise and think of a way to account for it and build better representative models for follicle growth. The purpose of this work is to come up with a robust model which can project the superovulation cycle outcome based on the hormonal doses and patient response and hence provide a treatment guideline to enhance the success rate of the procedure.
AB - In-vitro Fertilization (IVF) is the most common technique in Assisted Reproductive Technology (ART). It has been divided into four stages; (i) superovulation, (ii) egg retrieval, (iii) insemination/fertilization and (iv) embryo transfer. The first stage of superovulation is a drug induced method to enable multiple ovulation, i.e., multiple follicle growth to oocytes or matured follicles in a single menstrual cycle. IVF being a medical procedure that aims at manipulating the biological functions in the human body is subjected to inherent sources of uncertainty and variability. Also, the interplay of the hormones with the natural functioning of the ovaries to stimulate multiple ovulation as against a single ovulation in a normal menstrual cycle makes the procedure dependent on several factors like the patient's condition in terms of cause of infertility, actual ovarian function, responsiveness to the medication. The treatment requires continuous monitoring and testing and this can give rise to errors in observations and reports. These uncertainties can be observed in the form of measurement noise in the available data. Thus, it becomes essential to look at the process noise and think of a way to account for it and build better representative models for follicle growth. The purpose of this work is to come up with a robust model which can project the superovulation cycle outcome based on the hormonal doses and patient response and hence provide a treatment guideline to enhance the success rate of the procedure.
UR - https://www.scopus.com/pages/publications/84953874487
UR - https://www.scopus.com/pages/publications/84953874487#tab=citedBy
M3 - Conference contribution
AN - SCOPUS:84953874487
T3 - Food, Pharmaceutical and Bioengineering Division 2014 - Core Programming Area at the 2014 AIChE Annual Meeting
SP - 446
EP - 450
BT - Food, Pharmaceutical and Bioengineering Division 2014 - Core Programming Area at the 2014 AIChE Annual Meeting
PB - AIChE
T2 - Food, Pharmaceutical and Bioengineering Division 2014 - Core Programming Area at the 2014 AIChE Annual Meeting
Y2 - 16 November 2014 through 21 November 2014
ER -